Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...

Federal officials announced Ozempic, Wegovy and 13 other drugs are on a list of medications the government is targeting for ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

The Biden administration says it will be including weight loss drugs like Ozempic and Wegovy in the next round of drug ...

List of drugs account for $41 billion in annual Medicare spending, the Biden administration said.